Splanchnic and peripheral release of 3-methylhistidine in relation to its urinary excretion in human infection

J Sjölin, H Stjernström, S Henneberg, E Andersson, J Mårtensson, G Friman, J Larsson

48 Citationer (Scopus)


The present investigation was undertaken in order to determine the release of 3-methylhistidine (3MH) from the splanchnic region and from the leg, and the contributions these make to the increase in urinary 3MH excretion in infection. Thirteen febrile patients with infection were investigated. After an overnight fast, hepatic vein, femoral vein, and radial artery catheterizations were performed. Splanchnic and leg blood flows were determined by dye dilution technique. Plasma 3MH was analyzed by a modified HPLC method. The release of 3MH from the leg was 0.064 +/- 0.007 mumol/min (+/- SE) and from the splanchnic region 0.012 +/- 0.013 mumol/min. These releases of 3MH constitute 27% +/- 2% and 8% +/- 6% of the individual urinary excretions, respectively. With increasing degree of catabolism, measured as individual 3MH increase above baseline excretion or as the 3MH to creatinine ratio (3MH:Cr), the relative contribution to urinary excretion from the leg was increased (individual increase, P = 0.08; 3MH:Cr, P less than 0.01). Since this contribution was not decreased in the more catabolic patients, as would have been expected if the increase in urinary 3MH originated elsewhere, it is concluded that skeletal muscle is the source, and these results thus validate the use of urinary 3MH excretion as a marker of myofibrillar protein catabolism in infected patients.
Udgave nummer1
Sider (fra-til)23-9
Antal sider7
StatusUdgivet - 1 jan. 1989


Dyk ned i forskningsemnerne om 'Splanchnic and peripheral release of 3-methylhistidine in relation to its urinary excretion in human infection'. Sammen danner de et unikt fingeraftryk.